...
首页> 外文期刊>Stem cell research >GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant
【24h】

GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant

机译:Genyoi005-A:一种诱导的多能干细胞(IPSCS)从具有家族性血小板障碍的患者产生的患者,其具有相关的骨髓性恶性肿瘤(FPDMM)携带P.Thrl196Ala变体

获取原文

摘要

Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) is a rare platelet disorder caused by mutations in RUNX1. We generated an iPSC line (GENYOi005-A) from a FPDMM patient with a non-previously reported variant p.Thr196Ala. Non-integrative Sendai viruses expressing the Yamanaka reprogramming factors were used to reprogram peripheral blood mononuclear cells from this FPDMM patient. Characterization of GENYOi005-A included genetic analysis of RUNX1 locus, Short Tandem Repeats profiling, alkaline phosphatase enzymatic activity, expression of pluripotency-associated factors and differentiation studies in vitro and in vivo. This iPSC line will provide a powerful tool to study developmental alterations of FPDMM patients.
机译:具有相关的骨髓性菌肤(FPDMM)的家族性血小板障碍是突破1中突变引起的稀有血小板障碍。我们从具有非先前报告的变体P.Thrl196Ala的FPDMM患者生成了IPSC线(GenyoI005-A)。表达Yamanaka重编程因子的非综合仙海病毒用于从该FPDMM患者重新编程外周血单核细胞。 Genyoi005-A的表征-A runx1基因座的遗传分析,短串联重复分析,碱性磷酸酶酶活性,多能性相关因子和体内分化研究的表达。这种IPSC线将提供一个强大的工具,以研究FPDMM患者的发展改变。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号